Hosted on MSN54m
Injectable Anticoagulant Substantially Cuts Bleeding Risk in Afib
That's significant because the GI tract is the most common site of bleeding with DOACs, and this type of bleeding is the only one for which DOACs do not have a better risk profile ...
The American Journal of Managed Care1d
Abelacimab, a “Game Changer” for High-Risk Patients With AFib: Dr Ruff and Dr Bloomfield Elaborate on Latest Data From AZALEA-TIMI 71 Trial
Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...
Science Daily5h
Study shows anti-clotting drug reduced bleeding events in patients with atrial fibrillation
Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...
Anti-clotting drug significantly reduces bleeding events in patients with atrial fibrillation, clinical trial shows
Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...
The Healthy on MSN5mon
6 Silent Signs of AFib, According to a Cardiologist
An irregular heartbeat can raise your risk for heart failure and stroke. With up to 6 million Americans estimated to have ...
BioWorld6d
Boston Sci reports good data for Farapulse, Watchman afib systems
Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17.